IRF3 and cancer: Treatment of THP1 reporter cells in co-cultures with SKBR3 (HER2 + ) or OVCAR3 (NaPi2b + ) cancer cells with the Fc-wt ADCs induced IRF3 reporter activity more potently compared to the free payload (Fig. 1g).